Related references
Note: Only part of the references are listed.Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
Anne Ulrike Trendelenburg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Smad2 and 3 transcription factors control muscle mass in adulthood
Roberta Sartori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice
Stephen Welle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Down-Regulation of Akt/Mammalian Target of Rapamycin Signaling Pathway in Response to Myostatin Overexpression in Skeletal Muscle
Adel Amirouche et al.
ENDOCRINOLOGY (2009)
Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling
Micah J. Drummond et al.
JOURNAL OF APPLIED PHYSIOLOGY (2009)
Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle
Hans C. Dreyer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging
Micah J. Drummond et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
Role of beta-adrenoceptor signaling in skeletal muscle: Implications for muscle wasting and disease
Gordon S. Lynch et al.
PHYSIOLOGICAL REVIEWS (2008)
Nutrient signalling in the regulation of human muscle protein synthesis
Satoshi Fujita et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Signalling to translation: how signal transduction pathways control the protein synthetic machinery
Christopher G. Proud
BIOCHEMICAL JOURNAL (2007)
Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol
William O. Kline et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue
Leah J. Harcourt et al.
NEUROMUSCULAR DISORDERS (2007)
Systemic administration of β2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses
JG Ryall et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle
Hans C. Dreyer et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
The mTOR pathway in the control of protein synthesis
Xuemin Wang et al.
PHYSIOLOGY (2006)
The possible role of myostatin in skeletal muscle atrophy and cachexia
J Jespersen et al.
SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS (2006)
Myofibrillar protein synthesis in myostatin-deficient mice
S Welle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Regulation of muscle growth by multiple ligands signaling through activin type II receptors
SJ Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Growing roles for the mTOR pathway
DD Sarbassov et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Myostatin propeptide-mediated amelioration of dystrophic pathophysiology
S Bogdanovich et al.
FASEB JOURNAL (2005)
Muscle regeneration in the prolonged absence of myostatin
KR Wagner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality
ZF Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Pilot trial of albuterol in Duchenne and Becker muscular dystrophy
EG Fowler et al.
NEUROLOGY (2004)
Anticachectic effects of formoterol:: A drug for potential treatment of muscle wasting
S Busquets et al.
CANCER RESEARCH (2004)
Strength training and albuterol in facioscapulohumeral muscular dystrophy
EL van der Kooi et al.
NEUROLOGY (2004)
Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism
XY Zhu et al.
CYTOKINE (2004)
Regulation of muscle mass by myostatin
SJ Lee
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
Myostatin signals through a transforming growth factor β-like signaling pathway to block adipogenesis
A Rebbapragada et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Myostatin inhibits myoblast differentiation by down-regulating MyoD expression
B Langley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Loss of myostatin attenuates severity of muscular dystrophy in mdx mice
KR Wagner et al.
ANNALS OF NEUROLOGY (2002)
Functional improvement of dystrophic muscle by myostatin blockade
S Bogdanovich et al.
NATURE (2002)
The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum
JJ Hill et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Seven-transmembrane receptors
KL Pierce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification
G Pallafacchina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the β2-adrenergic receptor
RT Hinkle et al.
MUSCLE & NERVE (2002)
Expression of myostatin pro domain results in muscular transgenic mice
JZ Yang et al.
MOLECULAR REPRODUCTION AND DEVELOPMENT (2001)
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
SC Bodine et al.
NATURE CELL BIOLOGY (2001)
Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy
JT Kissel et al.
NEUROLOGY (2001)
Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old
GS Lynch et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Regulation of myostatin activity and muscle growth
SJ Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)